MAPKAPK5 and skin neoplasm: Silent mutations or single amino acid substitutions have been detected in lung, ovary and skin cancer tissue for ERK3, in lung and skin cancer tissue for ERK4, and in lung, melanoma and ovary cancer samples for MK5 (Tables 1, 2, 3; [48-54]).